Table 3.
Categorical changes in outcomes from baseline to 6 months (number, %).
| Outcome measures | Control group (n = 195a) |
Intervention group (n = 179b) |
p valuec | ||||
|---|---|---|---|---|---|---|---|
| Deteriorated | Unchanged | Improved | Deteriorated | Unchanged | Improved | ||
| FAMS Total | 121 (62.1) | 3 (1.5) | 71 (36.4) | 93 (52.0) | 3 (1.7) | 83 (46.4) | 0.048 |
| MSIS-29 Physical | 100 (51.3) | 8 (4.1) | 87 (44.6) | 86 (48.0) | 6 (3.4) | 87 (48.6) | 0.532 |
| MSIS-29 Psychological | 97 (49.7) | 20 (10.3) | 78 (40.0) | 66 (36.9) | 26 (14.5) | 87 (48.6) | 0.012 |
| 15D Index | 106 (54.4) | 2 (1.0) | 87 (44.6) | 77 (43.0) | 1 (0.6) | 101 (56.4) | 0.028 |
| EQ-5D-5L Index | 91 (46.7) | 16 (8.2) | 88 (45.1) | 86 (48.0) | 13 (7.3) | 80 (44.7) | 0.790 |
| EQ-VAS | 66 (41.5) | 16 (10.1) | 77 (48.4) | 48 (31.4) | 24 (15.7) | 81 (52.9) | 0.063 |
FAMS: Functional Assessment in Multiple Sclerosis; MSIS: Multiple Sclerosis Impact Scale-29; EQ-VAS: EuroQol–visual analogue scales; EQ-5D-5L: EuroQoL 5 Dimensions 5 Levels.
a
EQ-VAS: n = 159.
b
EQ-VAS: n = 153.
c
Deteriorated versus unchanged and improved combined.